GlassScriptPhysician profile
Sang Curtis Lee
NPI 1851382303
$2,867.14
in general payments reported to CMS, 2019-2025
25 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $972 · 2020: $517 · 2021: $155 · 2022: $504 · 2023: $173 · 2024: $408 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $692.16 | 2021-2025 | Tisseel |
| Amgen INC. | $442.58 | 2019-2020 | |
| Novo Nordisk INC | $323.23 | 2019-2021 | |
| Hologic Sales and Service, LLC | $148.23 | 2024 | Aptima |
| Lupin INC. | $140.42 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $140.11 | 2023-2024 | Myfembree |
| Vertical Pharmaceuticals, LLC | $135.59 | 2019-2020 | |
| Abbvie INC. | $119.40 | 2019-2020 | |
| Coopersurgical, INC. | $110.35 | 2022 | |
| Smith+Nephew, INC. | $102.38 | 2022 | |
| Aspira Women'S Health INC | $88.99 | 2019-2022 | |
| Covidien LP | $61.45 | 2019 | |
| Conmed Corporation | $48.23 | 2022 | |
| Aesculap, INC. | $40.42 | 2019 | |
| Therapeuticsmd, INC. | $37.71 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $35.82 | 2019 | |
| Pfizer INC. | $33.71 | 2019 | |
| Merck Sharp & Dohme LLC | $28.84 | 2019-2020 | |
| Daiichi Sankyo INC. | $27.90 | 2020 | |
| Astellas Pharma US INC | $24.72 | 2025 | Veozah |
| Agile Therapeutics, INC. | $21.00 | 2021 | |
| Amag Pharmaceuticals, INC. | $20.70 | 2019 | |
| Eisai INC. | $16.99 | 2019 | |
| Vivus LLC | $14.42 | 2019 | |
| Duchesnay USA Incorporated | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sang Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.